A total organophosphorus pesticide exposure study was conducted in Washington State in 1998 in a sample population of 13 children aged 2.5-5.5 years. The children were roughly split between rural and suburban populations and had been previously identified as having potentially elevated organophosphorus pesticide exposures. One component of the study was urine collection and analysis. Urine samples were collected from each subject up to four times in 24 h in two different seasons. Samples were collected at specific time points: before bed, first morning void, after lunch, and before dinner. Urine samples were analyzed initially for the six nonspecific dialkylphosphate (DAP) metabolites and subsequently for eight specific metabolites including malathion dicarboxylic acid (MDA), 3,5,6-trichloro-2-pyridinol (TCPy), and paranitrophenol (PNP). Relatively large percentages of the urine samples contained quantifiable amounts of two of the nonspecific DAP metabolites (DMTPF97%; DETPF67%), and three of the specific metabolites (MDA (71%), TCPy (79%), and PNP (96%)). A percent deviation analysis was employed to determine which of the spot sample time points was the best predictor of the estimated volume-weighted daily average. Of the four spot samples collected, first morning void samples were consistently found to be the best predictors of weighted-average daily metabolite concentration. This finding also held when the data were creatinine-adjusted. The results of this analysis suggest that if spot sampling is to be conducted as part of a biological monitoring study, first morning void samples should be preferentially collected.
Introduction
Collection of urine for use in evaluating biomarkers of exposure has become relatively common due to the rapid metabolism and excretion patterns of some environmental contaminants of concern. Analysis of urine samples for relevant metabolites can provide critical information for estimation of human exposure to environmental contaminants and for evaluation of predictive models used in regulatory decision making. Since levels of potential biomarkers in urine vary as a result of temporal variation in both exposure and physiologic processes, timing of sampling may affect analytical results (Hinwood et al., 2002) . Evaluation of urinary output is most straightforward if urine collection is complete (i.e., all output over periods of 24 h or more is captured). In practice, this can be very difficult, especially in some populations such as children. Consequently, spot samples are often gathered instead. Spot samples are single void urine samples, which can be collected at any time during the day.
If a single spot sample is to be collected per day, first morning voids (FMVs) are often selected on the basis of the assumption that the FMV provides an integrated sample over a relatively long part of the day and is therefore more likely to be representative. However, this assumption has not been validated, and no clear standards exist for correction for urine volume, contaminant excretion, dilution, or time between exposure and void (Hwang et al., 1997) .
Metabolites of organophosphorus (OP) pesticides are among the biomarkers frequently assayed using spot sample techniques. In a variety of populations, including young children, OP pesticide metabolite concentrations in spot urine samples have been used to estimate exposure (Loewenherz et al., 1997; Aprea et al., 2000; O'Rourke et al., 2000; Adgate et al., 2001) . As with other chemicals, where recent exposure is estimated by urinary biomonitoring, most OP pesticide metabolites have short biological half-lives, generally on the order of 2 days or less (WHO, 1986) . This quick excretion time brings in to question the appropriateness of spot sampling in studies of OP pesticide exposure. The analysis presented here investigates the relative ability of single spot samples collected at different time points throughout the day to approximate total daily excretion for several OP pesticide metabolites.
Data employed in this analysis were collected during a total exposure study conducted in 1998 in Washington State. As part of the sampling strategy, four urine samples were collected over a 24-h period from each child during each of two sampling cycles. Urine samples were initially analyzed for the six nonspecific dialkylphosphate (DAP) metabolites and subsequently for eight specific metabolites. Creatinine was also assayed. These data provide opportunity for examination of the consequences of alternative urine sampling strategies including the relative merits of multiple versus single daily samples and the effect of creatinine adjustment on analytical results.
Methods

Study Population
Potential study participants included families with children aged 2-5 years, and families were recruited from a population previously enrolled in two larger pesticide exposure studies (Lu et al., 2001; Koch et al., 2002) . The participants in these larger studies were originally recruited from pediatric clinics in two areas in Washington State: the urban and suburban King and Snohomish counties, and the rural and agricultural Chelan and Douglas counties. Biological samples collected in those studies were analyzed for the urinary DAP metabolites of OP pesticides, and children with high DAP levels were targeted for participation in the current study.
Parents were initially contacted by telephone in May of 1998. The study objectives and protocol were explained at that time. The full study protocol included not only the biological monitoring reported here, but also soil, household dust, toy and hand wipes, drinking water, 24-h air samples, and 24-h duplicate diet samples. Results of the environmental sampling (Kedan, 1999) and the duplicate diet sampling (Fenske et al., 2002) are reported elsewhere. In total, 13 families agreed to participate in this study: seven from King and Snohomish counties and six from Chelan and Douglas counties. In all of the rural residences, at least one adult was employed in agriculture. No adults in the suburban households were employed in agriculture.
Urine Sample Collection
Collection of four spot urine samples from each of the 13 children over the course of two 24-h periods was attempted (giving a maximum possible 26 person-days of data for any analyte). The first collection period took place in the summer (June-August) of 1998, followed by a second sampling in the fall (October) of 1998. The urine collection protocol employed was familiar to both the children and parents, as it was similar to the method employed in the previous studies in which the families were enrolled. Parents were provided with a commode specimen collection pan (Baxter Scientific, McGraw Park, IL, USA), prelabeled urine collection containers (118-ml polypropylene cups with screw cap lids), and Ziplockt bags to facilitate urine collection. Children either urinated into the commode inserts, which were then emptied into a polypropylene bottle, or urinated directly into the bottles. Parents were instructed to collect their child's entire void. The first urine sample was collected from each child before bedtime on the first sampling day. Subsequent samples consisted of the child's FMV, a sample after lunch, and a final sample in the late afternoon, just before dinner.
Parents were instructed to keep the samples in their refrigerator until collection by field staff. Samples were then transported to a University of Washington laboratory, and the urine volumes from each individual sample were measured. Samples were transferred to 15 ml polypropylene test tubes, and frozen until analysis. All urine samples were aliquoted and frozen within 24 h of collection.
Sample Analysis
Urine was analyzed at the University of Washington Department of Environmental Health laboratory for the six nonspecific DAP metabolites: dimethylphosphate (DMP), dimethylthiophosphate (DMTP), dimethyldithiophosphate (DMDTP), diethylphosphate (DEP), diethylthiophosphate (DETP), and diethyldithiophosphate (DEDTP). The methods for this analysis are reported by Moate et al. (1999) . Limits of detection ranged from 0.6 to 7.4 mg/l. Creatinine concentrations in these spot samples were ascertained using a colorimetric procedure based on the Jaffe´reaction (Creatinine Procedure No. 555, Sigma Diagnostics, Dorset, UK).
Samples were also analyzed for eight specific OP pesticide metabolites: 1,2,3-benzotriazine-4-one (BTA), 2-(diethylamino)-6-methylpyrimidin-4-ol/one (DEAMPY), malathion dicarboxylic acid (MDA), 3-chloro-7-hydroxy-4-methyl-2H-chromen-2-one/ol (CMHC), 5-chloro-1-isopropyl-(1 H)-1,2,3-triazol-3-ol/one (CIT), 2-isopropyl-4-methyl-6-hydroxypyrimidine (IMPY), paranitrophenol (PNP), and 3,4,5-trichloro-2-pyridinol (TCPy). These samples were analyzed at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA, and a detailed description of these methods is reported by Olsson et al. (2003) . Table 1 provides the major parent compounds of these specific metabolites, along with the limits of detection (in units of mg/l and nmol/l) for each compound.
Quality Control/Quality Assurance (QA/QC)
For the DAP analysis, a combination of matrix blanks, matrix-fortified ''spikes'', solvent blanks, and solvent-fortified ''spikes'' were analyzed with every batch of actual samples to evaluate quality control. Matrix blanks were comprised of a urine surrogate solution consisting of double deionized water and the 10 most significant components of urine by weight. Method coefficients of variation for DMTP and DETP in spiked samples were 17% and 14%, respectively (Moate et al., 1999) . Randomly selected samples were also rerun as batch replicates to measure analytical consistency. Replicate analyses of field samples from this study for DMTP yielded results as follows: 2.0 and 2.9 mg/l; 9.2 and 16.1 mg/l. For DETP, replicate pairs were ND and ND, 1.4 mg/l and oLOQ, 28.3 and 24.3 mg/l. External standard calibration curves were required to achieve a correlation coefficient (r 2 ) of 0.995 or higher. QC sample recoveries were required to be within a range of 73SD. The data were reviewed at two separate phases of the analysis by the Quality Assurance Officer (QAO) and the designated project Research Scientist. In cases where data did not meet the established criteria, the integrity of the standards was checked, and if necessary, the samples were reanalyzed.
Analyses for MDA, PNP, and TCPy were conducted at the Centers for Disease Control and Prevention. QC and QA data for the specific metabolites is reported by Olsson et al. (2003) . Replicate analyses of actual field samples were not conducted for these three analytes. Coefficients of variation of spiked quality control samples (at high and low spiking levels) were 14.0% and 15.8% for MDA, 10.7% and 9.9% for PNP, and 19.9% and 11.0% for TCPy.
Data Management
All samples containing concentrations below the limit of detection (LOD) were assumed to have concentrations equal to one-half the LOD. Values were not corrected for recovery efficiency.
Daily metabolite excretion was assessed using the four spot samples collected within a 24-h sampling period. Volumeweighted average daily concentration (ADC vol , mg metabolite/l urine) was calculated for each metabolite and each person-day as follows:
where C i is the metabolite concentration (mg/l) in a spot void and V i is the volume (l) of that void. Creatinine-adjusted and weighted average daily concentration (ADC cr , mg metabolite/ g creatinine) was calculated each metabolite and each personday according to the formula
where C m/cr,i is the creatinine-adjusted metabolite concentration (mg metabolite/g creatinine) in a spot void, C cr,i is the creatinine concentration (g creatinine/l urine) in that void, and V i is the volume (l) of the void.
Statistical Analysis
For each metabolite, the concentration in each spot sample from each available (complete) person-day was compared to the appropriate volume-weighted or creatinine-adjusted and weighted average daily concentration (ADC) in order to evaluate correspondence of single spot sample results with average daily results. This was done by computing the average (across person-days) absolute deviation (ADEV) between the metabolite concentration in an individual spot sample and the appropriate ADC
where i denotes time point (i.e., before bed, FMV, after lunch, or before dinner), j denotes person-day, and n is the number of person-days for which complete data were available (14 or 18 depending upon analyte F see below). Pesticide metabolite levels in spot and daily urine samples Kissel et al.
The average deviation was then divided by the average daily concentration of the metabolite over all available person-days (APDC) in order to yield a percent deviation
where i again denotes time point. Normalization was necessary because concentration ranges observed varied substantially across metabolites. Low percent deviation for a particular spot sample time point (i.e., before bed, FMV, after lunch, or before dinner) would indicate that sampling at that time provided a good prediction of daily excretion. Conversely, a high percent deviation would indicate that the concentration in a single sample collected at that time point would be more likely to deviate substantially from the average daily result. Large deviations in all spot samples for a particular metabolite would suggest that urinary excretion of the metabolite was erratic, while comparatively small deviations across spot samples would suggest that urinary excretion was approximately steady-state. The percent deviation analysis described above was conducted for each spot sample time point (before bed, FMV, after lunch, and before dinner) for the three specific metabolites and the two nonspecific metabolites that were found at detectable levels in high proportions of samples. All analyses were run with both the volume-weighted and creatinine-adjusted and weighted data.
Results
Sample Collection
In all, 100 urine samples were collected from 13 children in the spring and fall of 1999. Detailed demographic information, including age, sex, weight, and parental occupation for these children is presented elsewhere (Kedan, 1999; Fenske et al., 2002) . In brief, children were an average of 3.9 years old (SD ¼ 0.9 years) and the mean child weight was 16.8 kg (SD ¼ 2.8 kg). The sample population consisted of 10 girls and three boys. In total, 11 children in the spring and nine children in the fall provided complete sample sets, including one sample each before bed, FMV, after lunch, and before dinner. Two children in each season provided only three of the samples, and two children in the fall provided samples in an alternate order: FMV, after lunch, late afternoon, and before bed. These six sample sets were excluded from the current analysis, as shown in Figure 1 .
Creatinine concentration was not measured in at least one sample in two of the remaining 20 sample sets, resulting in a sample size (n) of 18 complete sample sets from a total of 11 children. DAP concentrations were measured in all 18, but specific metabolite concentrations were determined in only 14 sample sets from a total of nine children. Use of more than one sample set per child did not change the results of the analyses. Therefore, for statistical analyses involving the DAP metabolites, n ¼ 18 (72 individual spot urine samples), and for analyses including the specific metabolite concentrations, n ¼ 14 (56 individual spot urine samples) (see Figure 1) .
Sample Volumes
Spot sample time points did not differ significantly by volume. In both the 18 sample sets included in the DAP analysis and the 14 sample sets included in the specific metabolite analysis, FMV samples had the highest average volumes of the four samples (see Table 2 ). However, these volumes were not significantly higher than the average volumes of the other three spot sample time points for either the DAP analysis (ANOVA: P ¼ 0.3) or the specific metabolite analysis (ANOVA: P ¼ 0.4).
Metabolite Excretion
Of the three dimethyl DAP metabolites, DMTP was found most frequently at levels above the limit of quantitation (97%). DETP was the diethyl DAP metabolite detected in the highest number of samples (67%). The other four DAP metabolites were found with lower frequency. Three of the Figure 1 . Sample sets collected from 13 children during the spring and the fall. Samples were excluded due to incomplete set collection, lack of creatinine data, or lack of specific metabolite data to result in 18 complete sample sets for DAP analysis and 14 complete sample sets for specific metabolite analysis.
eight specific metabolites targeted in the analysis were found at levels above the limit of detection in a high proportion of samples: MDA (71%), TCPy (79%), and PNP (96%). The other five specific metabolites were found in detectable concentrations in fewer than 20% of the samples. Table 3 presents limits of detection (nmol/l), percentages of samples with concentrations above the limit of detection, and summary statistics for the five metabolites found most frequently in the urine samples. Creatinine data are also presented. Concentrations of creatinine and the five metabolites varied widely across all samples (''between-child range''), with up to a 300-fold difference for DMTP concentration, and a 70-fold difference for creatinine concentration. Large ranges were also observed when restricted to samples collected from individual children over the course of a single 24-h period (''within-child range''). This suggests that urinary output of both metabolites and creatinine was quite erratic in at least some instances.
In addition to the wide range of concentrations detected in the spot samples, there was also a wide range of excretion patterns. Excretion patterns varied by child, and did not have consistent peaks and valleys. To illustrate, Figure 2 presents urinary excretion patterns of DMTP and TCPy in the daily urine samples of four children (4 child-days). Urinary excretion patterns were similarly inconsistent for all 13 children for all five metabolites.
Deviations from Daily Averages
In order to determine whether any of the spot samples were preferentially predictive of estimated total daily excretion, the percent deviation from the average for each compound at each time point was calculated (see Table 4 ). FMV samples were found to be the best predictors of estimated total daily excretion (lowest percent deviation) for four of the five metabolites when the results were not creatinine-adjusted, and for all five metabolites when the results were creatinineadjusted. Pesticide metabolite levels in spot and daily urine samples Kissel et al.
To illustrate, when the total daily OP pesticide exposure was estimated by the creatinine-adjusted and weighted average of the four daily urine samples, the deviation between the total daily TCPy concentration and the concentration of TCPy in the FMV sample was much lower than for the other three spot samples (18% vs. 43%, 46%, and 51%, see Table 4 ). When the TCPy concentrations in the individual spot samples were graphed against the average daily TCPy concentration, the points in plot (b), representing the daily average vs. the FMV, fell most closely along the line of unity (see Figure 3) .
Discussion
Pesticide metabolite concentrations in children's urine were found to be highly variable in this study. One child's urinary DMTP, for instance, varied from 26 to 2200 nmol/l over the course of a single 24-h period. High variability is not surprising. The nature of children's exposures is more likely to be episodic and less likely to foster near steady-state excretion than some types of occupational exposures. Variability in children's metabolic rates may also be important. Procurement of 24-h samples is also more difficult from children than adults. It is therefore particularly important to understand the effects of sample timing on observed urinary levels in children. Ideally, this would be assessed by comparison of spot sample results and 24-h results. The current protocol did not include 24-h samples due to anticipated collection difficulties, but did provide spot samples at four specific times over the course of a day for a small sample of children. The weighted-average of these four samples is, in this case, the best estimate of urinary concentration possible, and probably represents about twothirds of total output.
The percent deviation approach used in this analysis was chosen because it allowed integration of both the precision and the accuracy of the relationship between the individual spot samples and the weighted daily averages. If a spot sample is a good predictor of the daily average, the values of both the correlation coefficient (r) and the slope (b) will be close to 1. Simply reporting correlation coefficients cannot fully characterize this relationship because good correlations can exist even if the ratios between the data are not one-to-one (i.e., good precision but poor accuracy). In addition, some spot samples may have relatively high contaminant concentrations, which could artificially increase correlation coefficients, but which would have less of an effect on percent deviations. FMV samples displayed less variance from weightedaverage concentrations than did samples taken at three other times during the day. This finding is not attributable to the relative volume of FMVs as FMV volumes collected were not significantly elevated in comparison to the other samples. While the volumes of the FMV samples may have been expected to be significantly larger than those collected at the other time points, this was not found to be the case. However, disproportionate undercollection of the FMV would lead to understatement of the representativenss of the FMV. Had larger FMV volumes been collected, conclusions drawn here regarding FMVs would only be strengthened.
The better predictive ability of the FMV sample also held whether or not creatinine adjustment was made and was not impacted by inclusion or exclusion of unequal person-days per participating individual. Results reported here therefore support the view that the FMV is the preferred spot sample if spot sampling is to be conducted.
The magnitudes of percent deviations at individual time points were found to vary by compound. This may be due to differences in physiological half-lives of the compounds. Feldman and Maibach (1974) conducted an intravenous dosing study of malathion and parathion in humans, and reported biological half-lives of 3 and 8 h, respectively, based on recovery of C 14 radioactivity (without determining specific chemical structure excreted). No intravenous data are available for chlorpyrifos; however, other researchers have conducted oral dosing studies of chlorpyrifos in humans, and reported biological half-lives for TCPy of the order of 20-30 h (Nolan et al., 1984; Griffin et al., 1999) . All such estimates of half-lives are based on the assumption that humans can be modeled as single continuous stirred tank reactors (CSTRs) and that elimination is first order. This is an approximation, and deviation from perfect first-order behavior would be expected in real populations. In addition, the cited studies were conducted with adults, and half-lives may differ in children.
Despite these caveats, results from this analysis were consistent with apparent physiological half-lives of the respective parent compounds. Maximal daily intraindividual ranges in urinary levels of the three specific metabolites most frequently found to be above LOD were ordered as MDA4PNP4TCPy. This is also reflected in percent deviations in the spot samples of these three compounds. In general, TCPy excretion was less erratic (lower percent deviation) than that of PNP and MDA.
The relatively poor predictive ability of the FMV sample for PNP and MDA illustrates the potential importance of sample timing for quickly excreted compounds, and suggests that spot sampling may only be appropriate for compounds with longer half-lives. Sampling strategies for compounds with very short half-lives, such as MDA and PNP, should be considered accordingly. For example, dietary exposures to a compound with a short half-life may be best characterized by a sample collected at night in order to capture the exposure from meals eaten during that day. Urinary creatinine was also found to be highly variable. Creatinine concentrations varied as much as 70-fold interindividually (across all samples) and 16-fold intraindividually (within a single 24-h period). Other researchers have also reported large variation in creatinine excretion in populations of young children (O'Rourke et al., 2000) . Creatinine adjustment did appear to reduce variability for FMV samples. For spot samples taken at other times of day, the utility of creatinine adjustment is unclear. The lack of consistent improvement in the predictive character of spot samples following creatinine adjustment observed here may simply be due to variability in children's creatinine excretion.
These results are based on data describing urinary levels of two nonspecific and three specific OP pesticides. Observed concentrations of the other target analytes (four nonspecific and five specific) were below the respective limits of detection far more frequently. This analysis would have been more robust were it able to include all target analytes. Additionally, given the small size of the study population, further research is needed to characterize fully the excretion patterns of these compounds. Finally, even FMV samples demonstrated some deviation from the daily weighted-average across compounds. This suggests that when feasible, full 24-h samples should be favored over spot samples.
Conclusion
This analysis examined the relative ability of urinary metabolite levels in spot samples collected at four distinct time points to approximate total daily exposure to five OP pesticide metabolites. Of the four spot samples collected, FMV samples were consistently found to be the best predictors of estimated total daily metabolite concentration. This finding also held when the data were creatinine-adjusted and weighted. The results of this study suggest that if spot sampling must be conducted, the FMV sample should be preferentially collected.
